NCSK distributes Appreciation Certificates among Outstanding Safai Karamcharis (See 'Corp Brief') Stakeholders explore actionable measures to promote inclusivity across financial institutions (See 'Corp Brief') SEBI - Writ court's intervention not needed in respect of a preliminary SCN proposing to conduct an inquiry & giving opportunity to petitioner to present objections: HC (See 'Legal Desk') EPFO urges establishments to utilize Employees' Enrolment Campaign, 2026 (See 'Corp Brief') SEBI - Regulator cannot substitute its own commercial judgment for business decision of a company in relation to funding its wholly owned subsidiary: SAT (See 'Legal Desk') MoS delivers inaugural address at BRICS Science Ministerial Meet at Chennai (See 'Corp Brief') SEBI - Noticee cannot be held liable for carrying out unregistered investment advisory activities or for promising assured returns where evidence does not exist to show that Noticee conducted core advisory activities: SEBI (See 'Legal Desk') Procurement of tyres: CCI imposes penalty on Rekha Agencies and SS Marketing (See 'Corp Brief') Sonowal inaugurates Rs 428 Crore Projects at Paradip Port (See 'Corp Brief') Committee discusses Next Phase of UDAN & strengthening of Pilot Training Ecosystem (See 'Corp Brief') IPR - Trademark registration is liable for cancellation u/s 57(2) of Trade Marks Act if it is made without sufficient cause: HC (See 'Legal Desk') Office of Pr. CCA, Delhi, celebrates National Senior Citizens Day (See 'Corp Brief') 29 FDI Investments worth Rs.4,895 Crore reported under Revised Framework (See 'Corp Brief') Aadhaar App crosses 5 crore Downloads (See 'Corp Brief') SARFAESI - In respect of monies recoverable from a defaulting entity, the dues payable to a bank, being financial creditor, do not take precedence, over dues owed to the EPFO: HC (See 'Legal Desk') CSIR-CRRI and CSIR-AMPRI organise Workshop on Innovative Materials (See 'Corp Brief') DFS organises Workshop to Strengthen Implementation of Reservation Policy (See 'Corp Brief') IBC - Payment or transaction involving company's assets during insolvency moratorium without court approval is illegal: NCLT (See 'Legal Desk') Experts from DGFT, EXIM Bank and Digital Commerce share Practical Insights with MSMEs (See 'Corp Brief') Chhattisgarh emerges as First inland State to initiate Exports of Value-Added Tilapia products (See 'Corp Brief') IBC - Writ remedy cannot be invoked where petitioner does not challenge any order passed by either Tribunal but merely seeks directions relating to listing, constitution of special bench & restraint on pending proceedings - costs of Rs 25000 imposed on petitioner: HC (See 'Legal Desk') Digital Public Infrastructure is a Necessity, not a Luxury: MoS (See 'Corp Brief') IPR - Fundamental test in trade dress passing off action is one of overall impression and similarity, rather than side-by-side comparison of minor differences: HC (See 'Legal Desk') RDI Fund 'Conflict of Interest' policy protected by Stringent Safeguards: MoS (See 'Corp Brief') BRICS Youth Council Meeting and BRICS Youth Summit held successfully in Gandhinagar (See 'Corp Brief') PMLA - Accused has no vested or matter-of-right entitlement to conversion of non-bailable warrant into bailable warrant: HC (See 'Legal Desk') RM to hold bilateral talks with his Japanese counterpart in New Delhi (See 'Corp Brief') IBC - Only crystallised claims as on effective date are payable on pro-rata basis from designated Operational Creditors Settlement Amount: SC (See 'Legal Desk') 'Friends of MY Bharat': A New Global Youth Connect launched (See 'Corp Brief') RDDBFI - Borrowers cannot cherry-pick figures from bank certificates while ignoring standard accounting treatment of interest after NPA classification: SC (See 'Legal Desk') Tete-a-tete around AI in banking sector often begins with algorithms (See CORP EINSICHT)

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.